In recent years the literature has recorded a progressive increase in the prevalence of adenocarcinoma of the esophagogastric junction. Several factors can interfere with the morbidity and mortality of surgical treatment.
Tercioti-Junior V. +4 more
core
Background Tubular anastomosis is commonly used in proximal gastrectomy; however, its use in stage II esophagogastric conjugate cancer is currently unclear.
Zhixing Zhang +6 more
doaj +1 more source
Effect of different surgical approaches on the survival and safety of Siewert type II esophagogastric junction adenocarcinoma: a systematic review and meta-analysis. [PDF]
Zheng H +5 more
europepmc +1 more source
A novel nomogram based on clinical blood indicators for prognosis prediction in curatively resected esophagogastric junction adenocarcinoma patients. [PDF]
Liu CT +10 more
europepmc +1 more source
Siewert type II adenocarcinoma of esophagogastric junction: treatment status
The incidence of adenocarcinoma of esophagogastric junction (AEG) has been increased continuously in the past decades, especially in western countries. Siewert type II is regard as the true AEG because of its location, however, the treatment for Siewert ...
Zang, Lu, Li, Shu-Chun
core
Can the prognostic nutritional index predict survival in patients with gastric and esophagogastric junction adenocarcinoma? [PDF]
Sağdıç MF +4 more
europepmc +1 more source
Esophagogastric junction adenocarcinoma: Preoperative chemoradiation or perioperative chemotherapy? [PDF]
Laxague F, Schlottmann F.
europepmc +1 more source
Can Spectral CT Complement Biopsy for MSI/dMMR Assessment in Esophagogastric Junction Adenocarcinoma? [PDF]
Méndez RJ, Nava Á.
europepmc +1 more source
SIRGs score may be a predictor of prognosis and immunotherapy response for esophagogastric junction adenocarcinoma. [PDF]
OuYang LY +8 more
europepmc +1 more source

